Abbott Laboratories, Inc. ABT recently announced the receipt of the FDA approval for the Alinity i laboratory traumatic brain injury (TBI) blood test. This will be the first commercially available TBI ...

CT scan of a brain of a patient with subdural hemorrhage, interhemispheric hemorrhage and cerebral edema from trauamatic brain injury (TBI). (CT scan of a brain of a patient with subdural hemorrhage, ...

Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...

-- Abbott's Alinity™ m Resp-4-Plex assay will allow healthcare workers to test for four viruses in one test, a critically important tool as flu presents with similar symptoms -- The test helps save on ...

AUSTIN (KXAN) — Researchers at the University of Texas at Austin’s PsyBrain Lab helped develop the first commercially-available laboratory test for traumatic brain injury, or TBI, in the U.S., UT ...

A breakthrough technology developed by Abbott could help assess victims of mild traumatic brain injuries (TBIs) and help inform the treatment of concussions caused by participation in contact sports, ...

The FDA urged clinical laboratories and healthcare providers to retest any patients who have recently received a positive result from two of Abbott’s PCR COVID-19 assays after identifying a heightened ...

According to the U.S. Centers for Disease Control (CDC), most sexually active adults will experience HPV infections; new test detects those HPV genotypes that could lead to cancer Abbott (ABT)'s new ...

Abbott has recalled two of its Alinity COVID-19 test kits after finding they can yield false positive results. Abbott is recalling its Alinity m SARS-CoV-2 AMP kit and Alinity m Resp-4-Plex AMP kit, ...